User login
- /content/duvelisib-response-rate-encouraging-phase-2-primo-trial-patients-r/r-ptcl
- /fedprac/article/233068/t-cell-lymphomas/duvelisib-response-rate-encouraging-phase-2-primo-trial
- /hematologynews/article/233068/t-cell-lymphomas/duvelisib-response-rate-encouraging-phase-2-primo
- /oncologypractice/article/233068/t-cell-lymphomas/duvelisib-response-rate-encouraging-phase-2-primo
- /hematology-oncology/article/233068/t-cell-lymphomas/duvelisib-response-rate-encouraging-phase-2